Inhibitors of extracellular signal-regulated kinase
US12404259B2 · kind B2 · utility
0Cited by
3References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 18, 2024 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Oct 18, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound 1,1-dioxido-2,3-dihydrothiophen-3-yl 4-phenoxybenzenesulfonate, pharmaceutical compositions thereof, and use of the compound and the pharmaceutical compositions for treating cancer and pulmonary diseases are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.